| Name | Walgreens #5223 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 3915 W Saginaw Hwy, Lansing, Michigan 48917 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (517) 703-0593 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
The United States is seeing a surge of coronavirus disease (COVID-19) cases in just a couple of days, reporting its second death.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Second Circuit has agreed with Lilly's position that a class should not have been certified in a pending third-party payor suit, in which unions and insurers who act as third-party payors alleged that they overpaid for Zyprexa prescriptions. The court also agreed with Lilly that plaintiffs' overpricing claims should not go forward.
People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
› Verified 4 days ago
| NPI Number | 1679580674 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #05223 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 3915 W Saginaw Hwy, Lansing, MI 48917 |
| Phone Number | 517-703-0590 |
News Archive
The United States is seeing a surge of coronavirus disease (COVID-19) cases in just a couple of days, reporting its second death.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Second Circuit has agreed with Lilly's position that a class should not have been certified in a pending third-party payor suit, in which unions and insurers who act as third-party payors alleged that they overpaid for Zyprexa prescriptions. The court also agreed with Lilly that plaintiffs' overpricing claims should not go forward.
People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
› Verified 4 days ago
News Archive
The United States is seeing a surge of coronavirus disease (COVID-19) cases in just a couple of days, reporting its second death.
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Second Circuit has agreed with Lilly's position that a class should not have been certified in a pending third-party payor suit, in which unions and insurers who act as third-party payors alleged that they overpaid for Zyprexa prescriptions. The court also agreed with Lilly that plaintiffs' overpricing claims should not go forward.
People with multiple sclerosis (MS) who have relapses within the first five years of onset appear to have more severe disability in the short term compared to people who do not have an early relapse, according to a new study published in the November 4, 2009, issue of Neurology®, the medical journal of the American Academy of Neurology. The study is one of the first to examine how MS relapses affect people during different time periods of the disease.
A new study by researchers at Imperial College London, UK, discusses the effect of a vaccine dose, specifically the BNT162b2 candidate (also known as the ‘Pfizer-BioNTech' vaccine), on neutralizing antibody titers in individuals who have already been infected with the virus.
Celsion Corporation, a leading oncology drug development company, today provided an update on the progress of its pivotal ThermoDox® Phase III "HEAT" trial for the treatment of hepatocellular carcinoma (HCC), the most common form of primary liver cancer. Following recent regulatory approvals in China, Malaysia, Thailand and the Philippines, the study is now enrolling patients in eleven countries, with the majority of clinical sites located in the Asia Pacific region where HCC is most prevalent.
› Verified 4 days ago
Rite Aid Pharmacy 04482 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 3700 W Saginaw St, Lansing, Michigan 48917 Phone: (517) 321-7746 | |
Cvs Pharmacy #08278 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5118 S Martin Luther King Blvd, Lansing, Michigan 48911 Phone: (517) 272-5424 | |
Cvs Pharmacy #16139 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 500 E Edgewood Blvd, Lansing, Michigan 48911 Phone: (517) 882-4845 | |
Cvs Pharmacy #16162 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 5609 W Saginaw Hwy, Lansing, Michigan 48917 Phone: (517) 327-0620 | |
Cvs Pharmacy #11246 Type: Pharmacy Location: 632 N Dibble Ave, Lansing, Michigan 48917 Phone: (517) 323-2382 |